We further detected CpG island methylation pattern located at the DLX5 promoter region (Figure 2B) by targeted bisulfite sequencing in samples of 111 de novo AML patients, 35 MDS patients, and 25 controls. This evidence concerns the gene DLX5 and myelodysplastic syndrome.